Last reviewed · How we verify
Mounjaro — clinical trials
Key trials
- Function and Lean Mass Preservation With Resistance Exercise During a GLP-1RA Treatment · NA
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese · PHASE2
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder · PHASE2
- Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes · PHASE3
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial · PHASE2, PHASE3
- Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder · PHASE2
- Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs · NA
- Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer · PHASE2
- A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar · PHASE2, PHASE3
- Study of Tirzepatide for Recovery and Alcohol Use Management · PHASE2
- Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy · PHASE4
- Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes · PHASE2
See also
- Full profile: Mounjaro
- Side effects: /side-effects
- Dosage & administration: /dosage
- Mechanism of action: /mechanism
- Cost & pricing: /cost
- Drug interactions: /interactions
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing